BTI.V - Bioasis Technologies Inc.

TSXV - TSXV Delayed Price. Currency in CAD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-02-29
2019-02-28
2018-02-28
2017-02-28
Total Revenue
606.384
606.384
1,422
589.844
512.966
Cost of Revenue
0
0
10.443
467.868
429.851
Gross Profit
606.384
606.384
1,412
121.976
83.115
Operating Expenses
Research Development
2,034
2,034
1,954
946.808
783.778
Selling General and Administrative
3,174
3,174
4,314
4,452
2,285
Total Operating Expenses
5,208
5,208
6,269
5,399
3,069
Operating Income or Loss
-4,602
-4,602
-4,857
-5,277
-2,986
Total Other Income/Expenses Net
592.165
592.165
1,382
-42.035
-10.473
Income Before Tax
-4,056
-4,056
-3,473
-5,308
-2,991
Income from Continuing Operations
-4,056
-4,056
-3,473
-5,308
-2,991
Net Income
-4,056
-4,056
-3,473
-5,308
-2,991
Net Income available to common shareholders
-4,056
-4,056
-3,473
-5,308
-2,991
Basic EPS
-
-0.07
-0.06
-0.10
-0.07
Diluted EPS
-
-0.07
-0.06
-0.10
-0.07
Basic Average Shares
-
62,271
56,675
50,901
45,416
Diluted Average Shares
-
62,271
56,675
50,901
45,416
EBITDA
-
-4,531
-4,785
-5,218
-2,935